Boston Scientific Corp
BSX
Revenue
4.21B
▲89.00M▲2.16%
3 Months ChangeAssets
38.08B
▲970.00M▲2.61%
3 Months ChangeLiabilities
17.37B
▲633.00M▲3.78%
3 Months ChangeFree Cash Flow
-15.00M
▼-94.00M▼-118.99%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 10-Q
ID: 0000885725-24-000073
2024-10-23
Form 8-K
ID: 0000885725-24-000070
2024-08-01
Form 10-Q
ID: 0000885725-24-000068
2024-07-30
Form 8-K
ID: 0000885725-24-000063
2024-07-24
Form 8-K
ID: 0000885725-24-000060
2024-05-10
Form 8-K
ID: 0000885725-24-000050
2024-05-06
Form 8-K
ID: 0000885725-24-000048
2024-05-01
Form 10-Q
ID: 0000885725-24-000046
2024-04-24
Form 8-K
ID: 0000885725-24-000040
2024-04-04
Form 8-K
ID: 0000885725-24-000037